Effect of serotypes on clinical manifestations of dengue fever in adults

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 6, 2009, Pages 471-478

  Chan, Kah Sieong ^a   Chang, Jung San ^a,b   Chang, Ko ^a,c   Lin, Chien Chou ^d   Huang, Jyh Hsiung ^d   Lin, Wei Ru ^a   Chen, Tun Chieh ^a,b   Hsieh, Hsiao Chen ^a,c   Lin, Shu Hui ^a   Lin, Ju Chuen ^a   Lu, Po Liang ^a,b   Chen, Yen Hsu ^a,b   Lin, Chun Yu ^a,b   Tsai, Jih Jin ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d Centers for Disease Control   (Taiwan)

Author keywords

Dengue; Dengue hemorrhagic fever; Dengue virus

Indexed keywords

ADULT; ARTICLE; ASCITES; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; DENGUE VIRUS 3; DISEASE COURSE; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MYALGIA; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; RASH; SECONDARY INFECTION; SEROTYPE; TAIWAN; THROMBOCYTE; THROMBOCYTE TRANSFUSION; CHI SQUARE DISTRIBUTION; CLASSIFICATION; DENGUE VIRUS; HOSPITALIZATION; LEUKOCYTE COUNT; MIDDLE AGED; MONOCYTE; NONPARAMETRIC TEST; PATHOGENICITY; PATHOLOGY; RETROSPECTIVE STUDY; SEROTYPING; THROMBOCYTE COUNT; VIROLOGY;

CHI-SQUARE DISTRIBUTION; DENGUE; DENGUE VIRUS; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; RETROSPECTIVE STUDIES; SEROTYPING; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TAIWAN;

EID: 77954669637     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Stephenson JR. Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ. 2005;83:308-14.
2. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002;2:33-42.
3. Halstead SB. Is there an inapparent dengue explosion? Lancet. 1999;353:1100-1.
4. Lei HY, Huang JH, Huang KJ, Chang C. Status of dengue control programme in Taiwan-2001. Dengue Bulletin (Geneva). 2002;26:14-23.
5. Huang JH, Liao TL, Chang SF, Su CL, Chien LJ, Shu PY, et al. Laboratory-based dengue surveillance in Taiwan, 2005: a molecular epidemiologic study. Am J Trop Med Hyg. 2007;77: 903-9.
6. Shu PY, Chen LK, Yueh YY, Chow L, Chien LJ, Huang JH, et al. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diag Lab Immun. 2003;10:622-30.
7. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization; 1997.
8. King CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell chemokine production. J Virol. 2002;76:8408-19.
9. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol. 2008;8:478-86.
10. Kou Z, Quinn M, Chen H, Shanaka WW, Rodrigo I, Rose RC, et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol. 2008;80:134-46.
11. Halstead SB. Dengue: hematologic aspects. Semin Hematol. 1982;19:116-31.
12. Rosen L, Khin MM, U T. Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol. 1989;140:351-60.
13. Kalayanarooj S, Nimmannitya S. Clinical and laboratory presentations of dengue patients with different serotypes. Dengue Bulletin (Geneva). 2000;24.
14. Chungue E, Poli L, Roche C, Gestas P, Glaziou P, Markoff LJ. Correlation between detection of plasminogen crossreactive antibodies and hemorrhage in dengue virus infection. J Infect Dis. 1994;170:1304-7.
15. Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology. 1995;213:254-7.
16. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Lin YS, et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol. 2001;63:143-9.
17. Yang KD, Wang CL, Shaio MF. Production of cytokines and platelet activating factor in secondary dengue virus infections. J Infect Dis. 1995;172:604-5.
18. Lee MS, Hwang KP, Chen TC, Lu PL, Chen TP. Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. J Microbiol Immunol Infect. 2006;39:121-9.
19. Guzman MG. Deciphering dengue: the Cuban experience. Science. 2005;309:1495-7.
20. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Nisalak A, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997;176:322-30.
21. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38:172-80.
22. Guzman MG, Kouri G, Martinez E, Bravo J, Riveron R, Morier L, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/ DSS). Bull Pan Am Health Organ. 1987;21:270-9.
23. Diaz A, Kouri G, Guzman MG, Lobaina L, Bravo L, Martinez R, et al. Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. Bull Pan Am Health Organ. 1988;22:133-44.
24. McBride WJ, Bielefeldt-Ohmann H. Dengue viral infections, pathogenesis and epidemiology. Microbes Infect. 2000;2: 1041-50.
25. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, Halstead SB, et al. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol. 2000;152:793-9.
26. Halstead SB. Dengue. Lancet. 2007;370:1644-52.
27. Ko YC. Epidemiology of dengue fever in Taiwan. Gaoxiong Yi Xue Ke Xue Za Zhi. 1989;5:1-11. [Article in Chinese.]